Collegium Pharmaceutical (COLL) EV to EBITDA (2018 - 2026)
Collegium Pharmaceutical's EV to EBITDA came in at 2.68 for Q2 2026, up 28.5% from 2.08 a year earlier and up 70.7% from the prior quarter.
Powered by 
Analysis
Collegium Pharmaceutical (COLL) EV to EBITDA (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Collegium Pharmaceutical reported EV to EBITDA of -0.12; for FY2025, it came in at 2.67, up 22.5% from FY2024.
- Going back by year, EV to EBITDA was 2.18 in FY2024 (+2.7%), 2.12 in FY2023 (-40.3%), 3.55 in FY2022 (-30.5%) and 5.11 in FY2021 (+15.9%).
- The Q2 2026 figure represents the highest quarterly EV to EBITDA since Q3 2024.
- Year-over-year, EV to EBITDA increased in four of the last eight quarters, with growth averaging 8.8%.
- The fastest year-over-year change in EV to EBITDA over five years came in Q1 2022 (growth of 118.3%), and the weakest in Q1 2023 (a decline of 75.4%).
- Business Quant data shows COLL's EV to EBITDA at 1.57 (Q1 2026), 2.67 (Q4 2025) and 2.14 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Collegium Pharmaceutical | 735.44 Mn | -488.33 Mn | 110.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.68 |
| Mar 31, 2026 | 1.57 |
| Dec 31, 2025 | 2.67 |
| Sep 30, 2025 | 2.14 |
| Jun 30, 2025 | 2.08 |
| Mar 31, 2025 | 2.29 |
| Dec 31, 2024 | 2.18 |
| Sep 30, 2024 | 3.29 |
| Jun 30, 2024 | 2.22 |
| Mar 31, 2024 | 2.81 |
| Dec 31, 2023 | 2.12 |
| Sep 30, 2023 | 1.59 |
| Jun 30, 2023 | 1.68 |
| Mar 31, 2023 | 2.48 |
| Dec 31, 2022 | 3.55 |
| Sep 30, 2022 | 4.05 |
| Jun 30, 2022 | 6.56 |
| Mar 31, 2022 | 10.11 |
| Dec 31, 2021 | 5.11 |
| Sep 30, 2021 | 3.64 |
API Access
Collegium Pharmaceutical EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=COLL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();